Anna Wilson has finished her two-year tenure as a postbaccalaureate researcher in the Gutmann laboratory and will move to Boston to start medical school at Harvard this fall. Anna joined the lab as an undergraduate research trainee in the fall of 2019, eventually completing her senior honors thesis before graduating Summa Cum Laude from Washington […]
We are so excited to welcome Michelle to the Gutmann Laboratory. In her role, she will serve as one of the Gutmann Lab managers. Her previous research experience at the University of Missouri – Columbia was in cardiovascular physiology focused on calcium homeostasis in the heart. Her favorite part of working in the lab was […]
Dr. Dana Borcherding, a senior scientist in the laboratory of Dr. Angela Hirbe, recently found that the combination of two drugs targeting different growth control pathways in MPNST cells dramatically decreased tumor growth in mice. In their studies, they combined a TYK2 inhibitor with a MEK inhibitor to achieve this dramatic effect with minimal toxicity. […]
Dr. Yuan Pan, Assistant Professor at the University of Texas MD Anderson Cancer Center, was recently awarded a three-year grant from the Gilbert Family Foundation Vision Restoration Initiative to study how NF1 mutations in brain cells called oligodendroglial cells change their interactions with the optic nerve. In this grant, Dr. Pan’s team will work with Dr. Corina Anastasaki, Research […]
Dr. Susan Maloney, Research Assistant Professor in Psychiatry, was recently awarded a one-year grant from the Washington University Intellectual and Developmental Disabilities Research Center (IDDRC) to study social behavior in mice with different Nf1 gene mutations. In this grant proposal, Dr. Maloney will collaborate with Dr. Corina Anastasaki, Research Assistant Professor in Neurology, to identify the autism-related behaviors in Nf1-mutant […]
The Children’s Tumor Foundation (CTF) has announced a groundbreaking 3-year study, which it will fund for nearly $2 million, to determine if a DNA-based blood test can offer better understanding and ultimately earlier diagnosis of cancer predisposition in neurofibromatosis type 1 (NF1) patients. Approximately 7-15% percent of NF1 patients may develop malignant peripheral nerve sheath […]